Warning: fopen(includes/rss-cache/amazon-Books-Cancer) [function.fopen]: failed to open stream: No such file or directory in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 984
Warning: fwrite(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 985
Warning: fclose(): supplied argument is not a valid stream resource in /home/jen1527/public_html/stage4cancersite.com/includes/amazon.php on line 986
WITH early screening, detection and treatment, incidences of colon cancer will be reduced. Unfortunately, there are still many who do not have access to such screening due to lack of awareness or financial problems.
Bayer Colon Cancer Drug Regorafenib Extended Lives 29%, Halted Study Shows
Bayer AG (BAYN) said its cancer medicine regorafenib improved survival for people with advanced colon cancer by 29 percent, fleshing out details of a trial halted last year in order to give all the participants the new drug.
Identified a cause of resistance to colon cancer treatment
( IMIM (Hospital del Mar Research Institute) ) Spanish scientists point to an acquired mutation during treatment as the causative mechanism of therapeutic failure.This discovery leads to new perspectives to improve the efficiency of treatments, the survival of patients and to advance in customized treatments against cancer.
Jeanna Richelson nominated for Jefferson Award for community efforts to battle cancer
Every morning Robert Richelson makes a smoothie for his wife. “Sweetie?” he asks while she gets ready for work. “Do you want blueberries? Blueberries and banana? Strawberries and blueberries?”